Fakultät für Biologie
Refine
Has Fulltext
- yes (5)
Is part of the Bibliography
- yes (5)
Year of publication
- 2018 (5) (remove)
Document Type
- Doctoral Thesis (5)
Language
- English (5)
Keywords
- Angeborene Immunität (1)
- Aspergillus fumigatus (1)
- Bacterial infection (1)
- Bakteriophagen (1)
- Biene (1)
- Biofilm (1)
- E. coli Nissle 1917 (1)
- EHEC (1)
- Enterohemorrhagic Escherichia coli (1)
- Entwicklung (1)
- Farbensehen (1)
- Host defense (1)
- Host-pathogen interaction (1)
- Innate immunity (1)
- Komplexauge (1)
- Lambdoide Prophagen (1)
- Marine sponge-derived actinomycetes (1)
- Marine sponges (1)
- Netzhaut (1)
- Neutrophils (1)
- Probiotikum (1)
- Shigella flexneri (1)
- Spatiotemporal analysis (1)
- Staphylococci (1)
- Streptomyces (1)
- Stress (1)
- bees (1)
- color vision (1)
- compound eyes (1)
- lambdoid prophage (1)
- probiotica (1)
- retinal development (1)
- stx-Phagen (1)
- stx-phages (1)
Institute
- Graduate School of Life Sciences (5) (remove)
Shiga toxin producing E. coli strains (STEC) are a great concern to human health. Upon an infection with as few as 100 bacteria, humans can develop disease symptoms ranging from watery to bloody diarrhea or even develop the hemolytic uremic syndrome (HUS). The major factor contributing to the disease symptoms is Shiga toxin (Stx) which can bind to the eukaryotic cells in the intestine of the human and induce cell death via apoptosis. Based, among other things, on the microbiota composition, the impact of STEC can vary. Some bacteria of the microbiota can interfere with the colonization of STEC strains in the first place. Others cannot impair the colonization but interfere with the toxin production and there are still others which are even infected by stx encoding phages, being released from STEC strains. Those previously harmless bacteria subsequently contribute to the toxin increase and worsen the disease progression. Since the genetic information of Stx is encoded on a prophage, antibiotic treatment of patients can lead to an increased toxin and stx-phage release and is therefore not recommended. Several STEC epidemics in different countries, which even resulted in the death of some patients, demonstrated that there is an urgent need for alternative treatment strategies.
The E. coli strain Nissle 1917 (EcN) has been used as a probiotic to treat gastrointestinal infections for more than 100 years. It harbors several fitness factors which contribute to the establishment of an intact intestinal barrier in the human gut. Moreover, studies with EcN unraveled that the probiotic E. coli can interfere with the colonization of STEC strains and their toxin production. This study aimed to investigate if EcN could be a possible alternative or supplementary treatment strategy for STEC infected patients, or a preventive treatment for the patient’s close contact persons.
Therefore, EcN was firstly investigated for a possible stx-prophage integration into its’s genome which would eliminate it from being a potential treatment due to the possibility of disease worsening. Despite the presence of the stx-phage surface receptor YaeT, EcN demonstrated a complete resistance towards the lysis and the lysogeny by stx-phages, which was proven by PCR, phage-plaque assays and phage enrichment approaches. Transcriptome data could unravel that a lambdoid prophage in the genome of EcN is involved in the resistance towards the phage infection. Other commensal E. coli tested presented a stx-phage resistance as well and in silico analysis revealed that all of them harbor a complete lambdoid prophage besides the stx-phage susceptible K-12 strain MG1655. We assume that the resistance of EcN towards a stx-phage infection is connected to the presence of an intact lambdoid prophage which interferes with superinfection.
Further experiments regarding the impact of the microcin negative EcN mutant SK22D towards STEC strains depicted that SK22D did not only interfere with the toxin production but also negatively regulated the transcription of the entire stx-prophage in coculture with all STEC strains tested (O157:H7, O26:H11, O145:H25, O103:H2, O111:H- and two O104:H4 isolates from the 2011 outbreak in Germany). This influence on the pathogenic factor production was evinced to be cell contact independent as SK22D could even interfere with the pathogenic factor production when being separated from the STEC strain EDL933 by a Transwell membrane with the pore size of 0.4 µm. From this data we concluded, that factor(s) released by SK22D interfere with the lysis of STEC strains by stabilizing the lysogenic state.
Another positive aspect of EcN towards the pathogenicity of STEC strains was encountered when EcN was incubated with isolated stx-phages. The probiotic strain could reduce the infectivity of the phages towards a MG1655 lysis from ~ 1e7 pfus/ml to 0 after 44 h of incubation. Various approaches to determine the characteristics of the factor(s) of EcN which are involved in the phage inactivation depicted it to be a heat resistant stationary phase protein on the surface of EcN, which could be a component of its biofilm.
Regarding the protective role of EcN we could further evince that SK22D was capable of interfering with the lysogenic K 12 mediated increase of Stx and stx phages. Lysogenic K-12 strains were characterized by a huge increase of Stx and stx-phage production. The presence of SK22D anyhow, could interfere with this K-12 mediated pathogenic factor increase. Transwell and stx phage infection kinetics led to the proposal that SK22D interfered with the stx-phage infection of K-12 strains in the first place rather than disturbing the lysis of lysogenic K 12. The protection from the phage infection could be due to the growth of K 12 strains within the SK22D culture, whereby the phage susceptible strains are masked from phage detection.
Summarizing, this work could underline the beneficial attributes of EcN towards the STEC pathogenicity in vitro. These results should be considered as pioneers for future in vivo studies to enable EcN medication as a supportive STEC infection treatment strategy.
Marine sponge-associated actinomycetes are reservoirs of diverse natural products with novel biological activities. Their antibiotic potential has been well explored against a range of Gram positive and negative bacteria. However, not much is known about their anti-infective or anti-virulence potential against human pathogens. This Ph.D. project aimed to investigate the anti-infective (anti-Shiga toxin and anti-biofilm) potential of sponge-derived actinobacteria through identification and isolation of their bioactive metabolites produced and characterizing their mechanism of action by transcriptomics. This thesis is divided into three studies with the overall objective of exploring the anti-infective efficacy of actinomycetes-derived extracts and compound(s) that could possibly be used as future therapeutics.
The first study deals with investigation on the anti-Shiga toxin effects of sponge-associated actinomycetes. Diarrheal infections pose a huge burden in several developing and developed countries. Diarrheal outbreaks caused by Enterohemorrhagic Escherichia coli (EHEC) could lead to life-threatening complications like gastroenteritis and haemolytic uremic syndrome (HUS) if left untreated. Shiga toxin (Stx) produced by EHEC is a major virulence factor that negatively affects the human cells, leading them to death via apoptosis. Antibiotics are not prescribed against EHEC infections since they may enhance the risk of development of HUS by inducing the production and release of Stx from disintegrating bacteria and thereby, worsening the complications. Therefore, an effective drug that blocks the Stx production without affecting the growth needs to be urgently developed. In this study, the inhibitory effects of 194 extracts and several compounds originating from a collection of marine sponge-derived actinomycetes were evaluated against the Stx production in EHEC strain EDL933 with the aid of Ridascreen® Verotoxin ELISA assay kit. It was found that treatment with the extracts did not lead to significant reduction in Stx production. However, strepthonium A isolated from the culture of Streptomyces sp. SBT345 (previously cultivated from the Mediterranean sponge Agelas oroides) reduced the Stx production (at 80 μM concentration) in EHEC strain EDL933 without affecting the bacterial growth. The structure of strepthonium A was resolved by spectroscopic analyses including 1D and 2D-NMR, as well as ESI-HRMS and ESI-HRMS2 experiments. This demonstrated the possible application of strepthonium A in restraining EHEC infections.
VI
In the second study, the effect of marine sponge-associated actinomycetes on biofilm formation of staphylococci was assessed. Medical devices such as contact lenses, metallic implants, catheters, pacemakers etc. are ideal ecological niches for formation of bacterial biofilms, which thereby lead to device-related infections. Bacteria in biofilms are multiple fold more tolerant to the host immune responses and conventional antibiotics, and hence are hard-to-treat. Here, the anti-biofilm potential of an organic extract derived from liquid fermentation of Streptomyces sp. SBT343 (previously cultivated from the Mediterranean sponge Petrosia ficiformis) was reported. Results obtained in vitro demonstrated its anti-biofilm (against staphylococci) and non-toxic nature (against mouse macrophage (J774.1), fibroblast (NIH/3T3) and human corneal epithelial cell lines). Interestingly, SBT343 extract could inhibit staphylococcal biofilm formation on polystyrene, glass and contact lens surfaces without affecting the bacterial growth. High Resolution Fourier Transform Mass Spectrometry (HR-MS) analysis indicated the complexity and the chemical diversity of components present in the extract. Preliminary physio-chemical characterization unmasked the heat stable and non-proteinaceous nature of the active component(s) in the extract. Finally, fractionation experiments revealed that the biological activity was due to synergistic effects of multiple components present in the extract.
In the third study, anti-biofilm screening of 50 organic extracts generated from solid and liquid fermentation of 25 different previously characterized sponge-derived actinomycetes was carried out. This led to identification of the anti-biofilm organic extract derived from the solid culture of Streptomyces sp. SBT348 (previously cultivated from the Mediterranean sponge Petrosia ficiformis). Bioassay-guided fractionation was employed to identify the active fraction Fr 7 in the SBT348 crude extract. Further purification with semi-preparative HPLC led to isolation of the bioactive SKC1, SKC2, SKC3, SKC4 and SKC5 sub-fractions. The most active sub-fraction SKC3 was found to be a pure compound having BIC90 and MIC values of 3.95 μg/ml and 31.25 μg/ml against S. epidermidis RP62A. SKC3 had no apparent toxicity in vitro on cell lines and in vivo on the greater wax moth Galleria melonella larvae. SKC3 was stable to heat and enzymatic treatments indicating its non-proteinaceous nature. HR-MS analysis revealed the mass of SKC3 to be 1258.3 Da. Structure elucidation of SKC3 with the aid of 1D and 2D-NMR data is currently under investigation. Further, to obtain insights into the mode of action of SKC3 on S. epidermidis RP62A, RNA sequencing was done. Transcriptome data revealed that SKC3 was recognized by RP62A at 20 min and SKC3 negatively interfered with the central metabolism of staphylococci at 3 h. Taken
VII
together, these findings suggest that SKC3 could be a lead structure for development of new anti-staphylococcal drugs.
Overall, the results obtained from this work underscore the anti-infective attributes of actinomycetes consortia associated with marine sponges, and their applications in natural product drug discovery programs.
The superfamiliy of bees, Apiformes, comprises more than 20,000 species. Within the group, the eusocial species like honeybees and bumblebees are receiving increased attention due to their outstanding importance for pollination of many crop and wild plants, their exceptional eusocial lifestyle and complex behavioral repertoire, which makes them an interesting invertebrate model to study mechanisms of sensory perception, learning and memory. In bees and most animals, vision is one of the major senses since almost every living organism and many biological processes depend on light energy. Bees show various forms of vision, e.g. color vision, achromatic vision or polarized vision in order to orientate in space, recognize mating partners, detect suitable nest sites and search for rewarding food sources. To catch photons and convert light energy into electric signals, bees possess compound eyes which consists of thousands of single ommatidia comprising a fixed number of photoreceptors; they are characterized by a specific opsin protein with distinct spectral sensitivity. Different visual demands, e.g. the detection of a single virgin queen by a drone, or the identification and discrimination of flowers during foraging bouts by workers, gave rise to the exceptional sex-specific morphology and physiology of male and female compound eyes in honeybees. Since Karl von Frisch first demonstrated color vision in honeybees more than 100 years ago, much effort has been devoted to gain insight into the molecular, morphological and physiological characteristics of (sex-specific) bee compound eyes and the corresponding photoreceptors. However, to date, almost nothing is known about the underlying mechanisms during pupal development which pattern the retina and give rise to the distinct photoreceptor distribution. Hence, in Chapter 2 and 3 I aimed to better understand the retinal development and photoreceptor determination in the honeybee eye. In a first step, the intrinsic temporal expression pattern of opsins within the retina was evaluated by quantifying opsin mRNA expression levels during the pupal phase of honeybee workers and drones. First results revealed that honeybee workers and drones express three different opsin genes, UVop, BLop and Lop1 during pupal development which give rise to an ultraviolet, blue, and green-light sensitive photoreceptor. Moreover, opsin expression patterns differed between both sexes and the onset of a particular opsin occurred at different time points during retinal development. Immunostainings of the developing honeybee retina in Chapter 2 showed that at the beginning of pupation the retina consist only of a thin hypodermis. However, at this stage all retinal structures are already present. From about mid of pupation, opsin expression levels increase and goes hand in hand with the differentiation of the rhabdoms, suggesting a two-step process in photoreceptor development and differentiation in the honeybee compound eye. In a first step the photoreceptor cells meet its fate during late pupation; in a second step, the quantity of opsin expression in each photoreceptor strongly increase up to the 25-fold shortly after eclosion. To date, the underlying mechanisms leading to different photoreceptor types have been intensively studied in the fruit fly, Drosophila melanogaster, and to some extend in butterflies. Interestingly, the molecular mechanisms seemed to be conserved within insects and e.g. the two transcription factors, spalt and spineless, which have been shown to be essential for photoreceptor determination in flies and butterflies, have been also identified in the honeybee. In chapter 3, I investigated the expression patterns of both transcription factors during pupal development of honeybee workers and showed that spalt is mainly expressed during the first few pupal stages which might correlate with the onset of BLop expression. Further, spineless showed a prominent peak at mid of pupation which might initiates the expression of Lop1. However, whether spalt and spineless are also essential for photoreceptor determination in the honeybee has still to be investigated, e.g. by a knockdown/out of the respective transcription factor during retinal development which leads to a spectral phenotype, e.g. a dichromatic eye. Such spectral phenotypes can then be tested in behavioral experiments in order to test the function of specific photoreceptors for color perception and the entrainment of the circadian clock. In order to evaluate the color discrimination capabilities of bees and the quality of color perception, a reliable behavioral experiment under controlled conditions is a prerequisite. Hence, in chapter 4, I aimed to establish the visual PER paradigm as a suitable method for behaviorally testing color vision in bees. Since PER color vision has considered to be difficult in bees and was not successful in Western honeybees without ablating the bee’s antennae or presenting color stimuli in combination with other cues for several decades, the experimental setup was first established in bumblebees which have been shown to be robust and reliable, e.g. during electrophysiological recordings. Workers and drones of the bufftailed bumblebee, Bombus terrestris were able to associate different monochromatic light stimuli with a sugar reward and succeeded in discriminating a rewarded color stimulus from an unrewarded color stimulus. They were also able to retrieve the learned stimulus after two hours, and workers successfully transferred the learned information to a new behavioral context. In the next step, the experimental setup was adapted to honeybees. In chapter 5, I tested the setup in two medium-sized honeybees, the Eastern honeybee, Apis cerana and the Western honeybee, Apis mellifera. Both honeybee species were able to associate and discriminate between two monochromatic light stimuli, blue and green light, with peak sensitivities of 435 nm and 528 nm. Eastern and Western honeybees also successfully retrieve the learned stimulus after two hours, similar to the bumblebees. Visual conditioning setups and training protocols in my study significantly differed from previous studies using PER conditioning. A crucial feature found to be important for a successful visual PER conditioning is the duration of the conditioned stimulus presentation. In chapter 6, I systematically tested different length of stimuli presentations, since visual PER conditioning in earlier studies tended to be only successful when the conditioned stimulus is presented for more than 10 seconds. In this thesis, intact honeybee workers could successfully discriminate two monochromatic lights when the stimulus was presented 10 s before reward was offered, but failed, when the duration of stimulus presentation was shorter than 4 s. In order to allow a more comparable conditioning, I developed a new setup which includes a shutter, driven by a PC based software program. The revised setup allows a more precise and automatized visual PER conditioning, facilitating performance levels comparable to olfactory conditioning and providing now an excellent method to evaluate visual perception and cognition of bees under constant and controlled conditions in future studies.
The human-bacterial pathogen interaction is a complex process that results from
a prolonged evolutionary arms race in the struggle for survival. The pathogen employs
virulence strategies to achieve host colonization, and the latter counteracts using defense
programs. The encounter of both organisms results in drastic physiological changes
leading to stress, which is an ancient response accompanying infection. Recent evidence
suggests that the stress response in the host converges with the innate immune pathways
and influences the outcome of infection. However, the contribution of stress and the exact
mechanism(s) of its involvement in host defense remain to be elucidated. Using the model
bacterial pathogen Shigella flexneri, and comparing it with the closely related pathogen
Salmonella Typhimurium, this study investigated the role of host stress in the outcome of
infection.
Shigella infection is characterized by a pronounced pro-inflammatory response
that causes intense stress in host tissues, particularly the intestinal epithelium, which
constitutes the first barrier against Shigella colonization. In this study, inflammatory
stress was simulated in epithelial cells by inducing oxidative stress, hypoxia, and cytokine
stimulation. Shigella infection of epithelial cells exposed to such stresses was strongly
inhibited at the adhesion/binding stage. This resulted from the depletion of sphingolipidrafts
in the plasma membrane by the stress-activated sphingomyelinases. Interestingly,
Salmonella adhesion was not affected, by virtue of its flagellar motility, which allowed the
gathering of bacteria at remaining membrane rafts. Moreover, the intracellular replication
of Shigella lead to a similar sphingolipid-raft depletion in the membrane across adjacent
cells inhibiting extracellular bacterial invasion.
Additionally, this study shows that Shigella infection interferes with the host stress
granule-formation in response to stress. Interestingly, infected cells exhibited a nuclear
depletion of the global RNA-binding stress-granule associated proteins TIAR and TIA-1
and their accumulation in the cytoplasm.
Overall, this work investigated different aspects of the host stress-response in the
defense against bacterial infection. The findings shed light on the importance of the host
stress-pathways during infection, and improve the understanding of different strategies
in host-pathogen interaction.
Humans are continuously exposed to airborne spores of the saprophytic fungus Aspergillus fumigatus. In healthy individuals, local pulmonary host defence mechanisms can efficiently eliminate the fungus without any overt symptoms. In contrast, A. fumigatus causes devastating infections in immunocompromised patients. However, local host immune responses against A. fumigatus lung infections in immunocompromised conditions have remained largely elusive.
Given the dynamic changes in immune cell subsets within tissues upon immunosuppressive therapy, we dissected the spatiotemporal pulmonary immune response after A. fumigatus infection to reveal basic immunological events that fail to effectively control the invasive fungal disease. In different immunocompromised murine models, myeloid but not lymphoid cells were strongly recruited upon infection. Notably, neutrophils and macrophages were recruited to infected lungs in different immunosuppressed regimens. Other myeloid cells, particularly dendritic cells and monocytes were only recruited in the corticosteroid model after infection. Lymphoid cells, particularly CD4+ or CD8+ T-cells and NK cells were highly reduced upon immunosuppression and were not recruited after A. fumigatus infection. Importantly, adoptive CD11b+ myeloid cell transfer rescued immunosuppressed mice from lethal A. fumigatus infection. These findings illustrate that CD11b+ myeloid cells are critical for anti-A. fumigatus defence under immunocompromised conditions.
Despite improved antifungal agents, invasive A. fumigatus lung infections cause a high rate morbidity and mortality in neutropenic patients. Granulocyte transfusions have been tested as an alternative therapy for the management of high-risk neutropenic patients with invasive A. fumigatus infections. To increase the granulocyte yield for transfusion, donors are treated with corticosteroids. Yet, the efficacy of granulocyte transfusion and the functional defence mechanisms of granulocytes collected from corticosteroid treated donors remain largely elusive.
We aimed to assess the efficacy of granulocyte transfusion and functional defence mechanisms of corticosteroid treated granulocytes using mouse models.
In this thesis, we show that transfusion of granulocytes from corticosteroid treated mice did not protect cyclophosphamide immunosuppressed mice against lethal A. fumigatus infection in contrast to granulocytes from untreated mice. Upon infection, increased levels of inflammatory cytokines helped to recruit granulocytes to the lungs without any recruitment defects in corticosteroid treated and infected mice or in cyclophosphamide immunosuppressed and infected mice that have received the granulocytes from corticosteroid treated mice. However, corticosteroid treated human or mouse neutrophils failed to form neutrophil extracellular traps (NETs) in in vitro and in vivo conditions. Further, corticosteroid treated granulocytes exhibited impaired ROS production against A. fumigatus. Notably, corticosteroids impaired the β-glucan receptor Dectin-1 (CLEC7A) on mouse and human granulocytes to efficiently recognize and phagocytize A. fumigatus, which markedly impaired fungal killing. We conclude that corticosteroid treatment of granulocyte donors for increasing neutrophil yields or patients with ongoing corticosteroid treatment could result in deleterious effects on granulocyte antifungal functions, thereby limiting the benefit of granulocyte transfusion therapies against invasive fungal infections.